Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Dexlansoprazole for Injection

Approval Number

国药准字H20220032

Company南京博德生物制药有限公司

Registration Date

November 30, 2022

Drug Information

Generic Name

注射用右兰索拉唑

Dosage Form

注射剂

Strength

20mg

Drug Type

化学药品

Registration Date

November 30, 2022

Company Information

Applicant Company

Company Name南京博德生物制药有限公司

Company Address

南京经济技术开发区兴建路5-1号

Manufacturing Company

Company Name盛禾（中国）生物制药有限公司

Company Address

中国江苏南京市经济技术开发区兴建路5号三号楼

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy